CVC weighs $2bn sale of Dr Teal’s owner Arthea
Thursday, September 10, 2026 · first reported by Private Equity Wire
CVC Capital Partners exploring $2bn sale of Arthea (Dr Teal's, Bodycology, Cantu), acquired for $1.43bn in 2017; Moelis and William Blair advising on potential exit from personal care portfolio.
- Also named
- Moelis, William Blair
- Deal value
- $2B
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on CVC Capital Partners
Everything on this firm →More in Deals
From the same day- Warburg Pincus and Berkshire Partners agree $11.75bn sale of CPP to GE AerospacePrivate Equity Wire +2
- Cerberus agrees $1.6bn sale of Tenet Equity to CBREPrivate Equity Wire +1
- HOF Capital completes €1bn purchase of Porsche’s Bugatti Rimac, Rimac Group stakesPE Hub
- Renaissance Partners Agreed to Buy De Wave From Platinum EquityHedgeCo Insights
- Bregal Sagemount takes majority stake in A-Rent Test EquipmentPE Hub
- Great Point Partners exits MLM Medical Labs to LabcorpPE Hub